MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES

被引：0
|
作者：
Gaebler, J. A. [1 ]
Soto-Campos, G. [2 ]
Alperin, P. E. [3 ]
Hoogwerf, B. J. [4 ]
Wintle, M. [1 ]
Maggs, D. [1 ]
Han, J. [1 ]
Blickensderfer, A. [5 ]
Pencek, R. [1 ]
Bruhn, D. [6 ]
Peskin, B. R. [2 ]
机构：
[1] Amylin Pharmaceut Inc, San Diego, CA USA
[2] Archimedes Inc, San Francisco, CA USA
[3] Archimedes Inc, San Diego, CA USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Amylin Pharmaceut Inc, Chesterfield, MO USA
[6] Eli Lilly & Co, San Diego, CA USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A91 / A91
页数：1
相关论文
共 50 条
  • [31] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes
    Senoo, Yuki
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1529 - 1530
  • [32] Insulin icodec: A novel once-weekly treatment for diabetes
    Schaffner, Hannah
    Wiener, Jordyn
    Deluca, Amanda
    Genovese, Ariana
    Deeb, Alexander
    Deeb, Wasim
    Sheikh-Ali, Mae
    Sutton, David
    Gore, Ashwini
    Berner, Jason
    Huston, Jessica
    Goldfaden, Rebecca
    DIABETIC MEDICINE, 2024,
  • [33] Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
    Ildiko Lingvay
    Malik Benamar
    Liming Chen
    Ariel Fu
    Esteban Jódar
    Tomoyuki Nishida
    Jean-Pierre Riveline
    Daisuke Yabe
    Thomas Zueger
    Rosângela Réa
    Diabetologia, 2025, 68 (4) : 739 - 751
  • [34] Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
    Traina, Andrea N.
    Lull, Melinda E.
    Hui, Adrian C.
    Zahorian, Toni M.
    Lyons-Patterson, Jane
    CANADIAN JOURNAL OF DIABETES, 2014, 38 (04) : 269 - 272
  • [35] Exenatide once weekly in type 2 diabetes mellitus
    Bischoff, Lindsay A.
    Jabbour, Serge A.
    Miller, Jeffrey L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1297 - 1303
  • [36] Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
    Aroda, Vanita R.
    DeYoung, Mary Beth
    POSTGRADUATE MEDICINE, 2011, 123 (05) : 228 - 238
  • [37] Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study
    Tamborlane, William V.
    Bishai, Raafat
    Geller, David
    Shehadeh, Naim
    Al-Abdulrazzaq, Dalia
    Karoly, Eva
    Doehring, Orlando
    Carter, Debra
    Monyak, John
    David Sjostrom, C.
    DIABETES, 2021, 70
  • [38] PROJECTED COST-EFFECTIVENESS OF EXENATIDE ONCE WEEKLY VERSUS EXENATIDE BID FOR THE TREATMENT OF TYPE 2 DIABETES IN THE UK
    Wilson, B. P.
    Beaudet, A.
    Caputo, J.
    Timlin, L.
    VALUE IN HEALTH, 2011, 14 (07) : A476 - A476
  • [39] Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
    Hovelmann, Ulrike
    Brondsted, Lise
    Kristensen, Niels R.
    Ribel-Madsen, Rasmus
    Devries, J. Hans
    Heise, Tim
    Haahr, Hanne
    DIABETES, 2020, 69
  • [40] Insulin icodec: an insulin analogue suited for once-weekly dosing in type 2 diabetes
    Hovelmann, U.
    Brondsted, L.
    Kristensen, N. R.
    Ribel-Madsen, R.
    DeVries, J. H.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S316 - S316
12345